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Abstract
Distal pancreatectomy with en-bloc splenectomy has been considered the standard technique for management of benign and
malignant pancreatic disorders. However, splenic preservation has recently been advocated. The aim of this study was to
review the experiences of distal pancreatectomy using the open or the laparoscopic approach and to critically discuss the need
to perform splenectomy. Original articles published in the English literature of peer-reviewed medical journals were selected
for detailed analysis. In patients with malignant neoplasms in the body-tail of the pancreas, splenectomy has a negative
influence on long-term survival after resection. The incidence of diabetes after spleen-preserving distal pancreatectomy for
chronic pancreatitis is less than after en-bloc splenectomy. Spleen salvage eliminates the risk of overwhelming infections.
Laparoscopic spleen-preserving distal pancreatectomy is feasible and safe. Laparoscopic spleen-preserving distal pan-
createctomy may be preferable for the advantages of a minimally invasive approach.
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Introduction
In general, distal pancreatectomy is performed en-bloc
along with resection of the spleen. Most of the time, the
en-bloc pancreatic-spleen resection is performed for
technical reasons; it makes the operation short and easy
but does not offer any special advantage for the patient.
Overwhelming sepsis after distal pancreatectomy and
splenectomy has been reported [1]. Kimura et al. [2],
have described the technique of preserving both the
splenic artery and vein. In addition, Warshaw [3] has
described a technique of distal pancreatectomy in
which splenic vessels are ligated both at the level of
transection of the pancreas and again at the splenic
hilum, leaving the spleen to survive on blood flow
through the short gastric vessels. Others have described
techniques whereby the pancreas is dissected off the
splenic vessels completely [4].
The objective of the present study was to review the
experiences of distal pancreatectomy using the open or
the laparoscopic approach and to critically discuss the
need to perform splenectomy.
Open surgery
In the literature, in patients with left-sided chronic
pancreatitis and pancreatic tumours located in the
body-tail of the pancreas the technique most frequently
used was distal pancreatectomy with en-bloc resection
that included the spleen. However, in recent years,
spleen-preserving distal pancreatectomy has been used
more frequently. Spleen salvage is preferable because it
eliminates the rare but potentially fatal complications
of overwhelming infection with encapsulated bacterial
organisms [1].
Published data from two retrospective reviews
comparing patients who had surgery mainly for trauma
or pancreatitis, undergoing distal pancreatectomy with
and without splenectomy, had shown no differences in
complication rates between groups, concluding that
splenectomy should not be a routine part of distal
pancreatic resection [4,5]. On the other hand, Benoist
et al. [6] analysed 40 patients undergoing distal
pancreatectomy for indications other than chronic
pancreatitis. Fifteen patients underwent distal
pancreatectomy with spleen conservation and 25 had
splenectomy. Pancreatic left resection with sple-
nectomy turned out to have a lower morbidity rate, as
pancreatic complications such as fistula or subphrenic
abscess occurred more frequently in patients after
spleen-conserving surgery. More recently, Shoup et al.
[7] reported the series from the Memorial Sloan-
Kettering Cancer Center including 211 patients
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undergoing distal pancreatectomy. Splenectomy was
performed in 79 patients (63%) and splenic preserva-
tion in 46 (37%). The most common histopathological
conditions were neuroendocrine tumours (n=45) and
benign cystic tumours (n=44). Perioperative compli-
cations occurred in 49% of patients after splenectomy
and in 39% after splenic preservation. Perioperative
infectious complications and severe complications
were significantly higher in the splenectomy group
(28% and 11%), compared with the splenic preserva-
tion group (9% and 2%). The length of hospital stay
was 9 days post-splenectomy and 7 days post-splenic
preservation.
What is the evidence for and against distal pan-
createctomy with splenic preservation, in benign and
malignant pancreatic disorders?
Spleen preservation in patients with pancreatic
adenocarcinoma
There is no real consensus on the need to perform
spleen preservation in the setting of a malignant
neoplasm. In the large series of 235 distal pancreatec-
tomies reported by Lillemoe et al. [8], only 49 patients
(21%) underwent resection for adenocarcinoma of the
pancreas. They always recommend an en-bloc distal
pancreatectomy with splenectomy. Andre´n-Sandberg
et al. [9], also believe that splenectomy should be
routinely performed because splenic artery preserva-
tion is hazardous for oncologic radicality when distal
pancreatectomy is performed for cancer. However, this
argument should not be used against preservation of
the spleen. Involvement of the splenic vein, and the
splenic artery distant from the coeliac axis, is frequently
found, and does not preclude distal pancreatic resec-
tion for malignant tumours in the body-tail of the
pancreas. Mobilization of the caudal surface of the
body of the pancreas from the retroperitoneum is
performed after division of the splenic artery close the
coeliac trunk, followed by division of the splenic vein
close to the junction to the mesenteric vein. It allows an
extensive retroperitoneal lymph node dissection. The
spleen may be preserved by maintaining the integrity of
the short gastric vessels and the left gastro-epiploic
vessels (Warshaw’s technique). According to Balcom
et al. [10], spleen-sparing distal pancreatectomy
may also be preferable in the setting of a malignant
neoplasm not directly involving the spleen because it
is a putative mechanism for maintenance of immune
surveillance. Also, for Sasson et al. [11], whenever
possible, splenic conservation should be attempted
in patients undergoing total or distal pancreatectomy
for adenocarcinoma of the pancreas. Schwarz et al. [12]
have studied the impact of splenectomy on hospital
stay and survival after resection of pancreatic
adenocarcinoma. In this analysis, splenectomy has
no significant measurable impact on postoperative
recovery, but has a negative influence on long-term
survival independent of disease-related factors. The
authors concluded that splenectomy should be
avoided in the operative treatment of exocrine
pancreatic cancer at any localization.
Spleen preservation in patients with left-sided
chronic pancreatitis
The French surgeon Mallet-Guy [13] first described,
in the 1940s, the technique of spleen-preserving
pancreatic left resection for patients with chronic
pancreatitis. Since that time, the reasons why spleen-
preserving distal pancreatectomy was performed or not
performed, are not clear in the literature [14–21]
(Table I). In some reports, the incidence of splenic
preservation was rather low at 20%, as reported by
Rattner et al. [14], and 24% as reported by Sakorafas
et al. [18]. In some other reports, including our series,
the spleen was salvaged successfully in 31–57.9% of
cases [15–17,19–21]. The main reason for performing
pancreatic left resection with splenectomy is the find-
ing of pancreatic tissue firmly and densely adherent to
the splenic vessels. The en-bloc distal pancreatic-
spleen resection is mostly performed for technical
reasons, to make the operation short and easy, as
compared with spleen-preserving distal pancrea-
tectomy, a technically demanding and more time-
consuming procedure. We believe that—even in cases
of severe chronic pancreatitis followed by gross
pancreatic calcification, marked oedema and fibrosis
that also encase the splenic vessels—spleen-sparing
distal pancreatectomy should be encouraged, applying
the Warshaw’s technique with preservation of the short
gastric vessels. In other cases, the oedema resulting
from chronic inflammation surrounding the splenic
vessels may facilitate splenic vessel preservation and
splenic conservation.
Splenic preservation—apart from preventing post-
splenectomy sepsis—might also delay the onset of
diabetes mellitus. In some series, independent of
the volume of the gland resected, the incidence of dia-
betes mellitus was less after spleen-preserving distal
pancreatectomy than after en-bloc distal pancrea-
tectomy and splenectomy [17,21]. Nevertheless, the
latter technique should be indicated in cases of splenic
vein occlusion and gastric varices and in cases of
Table I. Spleen-sparing distal pancreatectomy in patients with
chronic pancreatitis: open approach
Author (year)
Pancreatic left
resection: no.
Spleen-sparing:
no. (%)
Rattner et al. [14] (1996) 20 4 (20)
Evans et al. [15] (1997) 13 4 (31)
Schoenberg et al. [16] (1999) 74 25 (34)
Govil et al. [17] (1999) 38 22 (58)
Sakorafas et al. [18] (2001) 38 9 (24)
Bauer et al. [19] (2002) 12 4 (33)
Ferna´ndez-Cruz et al. [20]
(2002) 41 16 (39)
Hutchins et al. [21] (2002) 90 29 (32)
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pseudocyst or necrosis of the pancreatic tail involving
the splenic hilum.
Spleen preservation in patients with cystic
pancreatic tumours
Serous cystadenoma and mucinous cystic neoplasms
(CyNP) are rare tumours that are often diagnosed in
middle-aged women. Most patients experience vague
abdominal pain and symptoms seemingly related to the
mass effect of the tumour. These neoplasms are usually
located in the body or tail of the pancreas and with high
frequency are either benign or premalignant lesions
[22,23]. However, two recent series of mucinous cystic
neoplasms describe invasive carcinoma in 36% [23]
and 29% [24]. Enucleation or pancreatic resection
have been advocated in open surgery to manage these
tumours. Is enucleation an appropriate method? Pyke
et al. [25] reported on eight enucleations of serous
cystadenomas: postoperatively there were two deaths
and four complications requiring reoperation (one case
of pancreatitis, one pancreatic pseudocyst and two
pancreatic fistulas). In the Johns Hopkins’s series the
incidence of pancreatic fistula after enucleation was
reported to be 50%, leading to a lengthy hospital stay
(19.5 days) [26]. Recently, Kiely et al. [27] have
introduced some major operative modifications, the
introduction of intraoperative ultrasound imaging to
identify the pancreatic duct and closure of the
pancreatic defect after enucleation. In this series,
despite these refinements in the technique, the
pancreatic fistula rate was 27%, and the hospital stay
was 12.6 days. We believe that tumour enucleation
appears to be a debatable procedure in patients with
CyNP. Tumour enucleation does not address the
malignant potential of these tumours and should be
used (in selected cases) with caution to avoid inade-
quate tumour margins. In the literature, when the
tumour was located in the body or tail of the pancreas,
the technique most frequently used was distal
pancreatectomy. In some series, it was not stated
whether there was conservation of the spleen at the
time of distal pancreatectomy [22,25,28–30]. In some
other series [26,31–34], distal pancreatectomy with
splenectomy was the technique most frequently used,
with the exception of Kiely’s report [27] (Table II).
Spleen preservation in patients with neuroendocrine
tumours
This group of patients is very heterogeneous and a
critical analysis of the results in the literature is difficult
and beyond the scope of this paper.
Laparoscopic surgery
Soper et al. [35] in 1994 were able to establish the
safety and efficacy of laparoscopic distal pancrea-
tectomy in an animal model, with no evidence of
pancreatic leaks or fistulae. Later, in 1996, Cuschieri
et al. [36] described the technique they used to perform
laparoscopic distal 70–80% pancreatectomy with
en-bloc splenectomy in a group of five patients with
intractable pain due to chronic pancreatitis. The
authors demonstrated that this operation can be
performed laparoscopically within an acceptable
operating time and without major complications. In
addition, with this technique, all patients achieved
sustained pain relief. Gagner et al. [37] in 1996
described laparoscopic spleen-preserving distal
pancreatectomy preserving the splenic artery and vein
in a series of patients with neuroendocrine tumours,
cystic tumours and chronic pancreatitis. However,
Vezakis et al. [38] demonstrated that laparoscopic
spleen-preserving distal pancreatectomy can be also
performed using the Warshaw’s technique. We also
encourage laparoscopic spleen-preserving pancrea-
tectomy (Lap SPDP) to prevent the potential long- and
short-term complications associated with splenectomy.
The question is whether it should be performed with
or without splenic vessel preservation (Warshaw’s
technique). Splenomegaly is a contraindication for
Warshaw’s method because the increased mass is
insufficiently nourished by the short gastric vessels.
Table II. Distal pancreatectomy for cystic tumours in the body-tail of the pancreas: open approach
Author (year) Number of patients
Distal pancreatectomy: no. (%)
Splenectomy Spleen-preserving
Pyke et al. [25] (1992) 17 NS NS
Talamini et al. [26] (1998) 19 14 (74) 5 (26)
Meyer et al. [28] (1999) 10 NS NS
Le Borgne et al. [29] (1999) 186 NS NS
Horvath et al. [31] (1999) 13 9 (70) 4 (30)
Shima et al. [30] (2000) 14 NS NS
Sarr et al. [22] (2000) 59 NS NS
Kalil et al. [32] (2002) 11 11 (100) –
Balzano et al. [33] (2003) 21 11 (52) 10 (48)
Kiely et al. [27] (2003) 11 4 (36) 7 (64)
Sheehan et al. [34] (2003) 34 32 (94) 2 (6)
NS, not stated.
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There is no doubt that by preserving the splenic artery
and vein, the blood supply to the spleen is well main-
tained and the danger of splenic necrosis and abscess
formation is reduced. On the other hand, distal
pancreatectomy with conservation of the splenic artery
and vein is both time- and labour-consuming.
Dissecting the splenic vessels from the pancreas may be
difficult in the presence of tumours distorting and
compressing the course of the vessels. Recently, we
have reported a prospective study to evaluate the
feasibility and outcome of Lap SPDP, with and with-
out splenic vessel preservation [39] (Figures 1 and 2).
Comparison of the groups demonstrated a statistically
significant difference in the parameters of operative
time and intraoperative blood loss, in favour of division
of the splenic vessels. In any case, as regards the
question of whether or not to conserve the splenic
vessels, we believe, in accordance with Warshaw [40]
‘if the goal is to save the spleen, having options allows
the surgeons to match the tactics to the terrain’.
In the literature, the indications for laparoscopic
distal pancreatectomy are neuroendocrine tumours
and benign-appearing tumours. In some series
laparoscopic distal pancreatectomy (Lap DP) is
performed in association with splenectomy [41–44]
(Table III). However, in some other series Lap SPDP
Figure 1. Laparoscopic spleen-preserving distal pancreatectomy
with splenic vessel preservation.
Figure 2. Laparoscopic spleen-preserving distal pancreatectomy
without splenic vessel preservation. Care should be taken when
transecting the splenic vessels at the splenic hilum to preserve the
short gastric vessels and gastro-epiploic vessels.
Table III. Laparoscopic distal pancreatectomy for tumours in the body-tail of the pancreas
Author (year)
Number of
patients
Distal pancreatectomy
with splenectomy: no. (%)
Spleen-preserving distal
pancreatectomy: no. (%)
Gagner et al. (1996) [37] 8* 2 (25) 5 (62)
Gagner et al. (1997) [45] 9* 2 (22) 6 (67)
Cuschieri et al. (1998) [41] 9 9 (100) –
Vezakis et al. (1999) [38] 6 1 (17) 5 (83)
Burpee et al. (1999) [46] 10 2 (20) 8 (80)
Azagra et al. (2000) [42] 10 10 (100) –
Patterson et al. (2001) [47] 15 12 (80) 3 (20)
Barlehner et al. (2001) [43] 5 5 (100) –
Park et al. (2002) [48] 23 11 (48) 12 (52)
Fabre et al. (2002) [49] 13 3 (23) 10 (77)
Gramatica et al. (2002) [50] 5 1 (20) 4 (80)
Mabrut et al. (2002) [51] 11 5 (45) 6 (55)
Masson et al. (2003) [52] 7 – 7 (100)
Nieuwenhove et al. (2003) [52] 5 2 (40) 3 (60)
Edwin et al. (2004) [44] 17 12 (71) 5 (29)
Shimizu et al. (2004) [54] 9 – 9 (100)
Ferna´ndez-Cruz et al. (2004) [55] 40 3 (7) 37 (93)
* Negative exploration in one patient.
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with or without splenic vessel preservation was the
most preferable technique [37,38,41–55] (Table III).
In our series of 40 patients spleen salvage was possible
in 92% [55]. However, after Lap SPDP splenic
complications were observed in 16.6% of patients, and
interestingly this complication was only observed in
patients undergoing Warshaw’s technique. This
complication may be suspected clinically with the
presence of fever and left upper abdominal pain.
Colour Doppler ultrasonography will show the area of
splenic infarct. Abscess formation can be prevented by
administration of antibiotics. A more serious compli-
cation is massive necrosis of the organ with local
infection that requires splenectomy, as occurred in one
of our patients. Nevertheless, Warshaw’s technique is
faster and less technically demanding than splenic
vessel preservation.
Conclusions
Splenectomy should not be a routine part of distal
pancreatic resection. Lessons learnt from patients with
malignant neoplasms in the body-tail of the pancreas
suggest that splenectomy has a negative influence on
long-term survival after resection. Also, in patients
undergoing distal pancreatic resection for chronic
pancreatitis, independent of the volume of the gland
resected, the incidence of diabetes mellitus was less
after spleen preservation than after en-bloc sple-
nectomy. In addition, spleen salvage should be
preferable because it eliminates the rare but potentially
fatal complications of overwhelming infection with
encapsulated bacterial organisms.
At present, there are no data comparing the open
and the laparoscopic approach in patients undergoing
distal pancreatic resection for benign-appearing
pancreatic disorders. However, laparoscopic spleen-
preserving distal pancreatectomy may be preferable for
the advantages of a minimally invasive approach:
reducing the parietal damage to the abdomen, accept-
able complications rate, reasonably short hospital stay
and early return of the patients to previous activities.
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